Night-time oral insulin therapy
US7384914B2 · kind B2 · utility
5Cited by
9References
59Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 6, 2004 |
| Grant date | Jun 10, 2008 |
| Priority date | — |
| Expiry date | Jan 6, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for protection of a mammal that has impaired glucose tolerance or early stage diabetes mellitus from developing overt or insulin dependent diabetes comprises administering an orally effective dose of a pharmaceutical formulation comprising insulin at nighttime, e.g., at or shortly before bedtime.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.